Literature DB >> 23941288

In vitro batch cultures of gut microbiota from healthy and ulcerative colitis (UC) subjects suggest that sulphate-reducing bacteria levels are raised in UC and by a protein-rich diet.

Nazeha A Khalil1, Gemma E Walton, Glenn R Gibson, Kieran M Tuohy, Simon C Andrews.   

Abstract

Imbalances in gut microbiota composition during ulcerative colitis (UC) indicate a role for the microbiota in propagating the disorder. Such effects were investigated using in vitro batch cultures (with/without mucin, peptone or starch) inoculated with faecal slurries from healthy or UC patients; the growth of five bacterial groups was monitored along with short-chain fatty acid (SCFA) production. Healthy cultures gave two-fold higher growth and SCFA levels with up to ten-fold higher butyrate production. Starch gave the highest growth and SCFA production (particularly butyrate), indicating starch-enhanced saccharolytic activity. Sulphate-reducing bacteria (SRB) were the predominant bacterial group (of five examined) for UC inocula whereas they were the minority group for the healthy inocula. Furthermore, SRB growth was stimulated by peptone presumably due to the presence of sulphur-rich amino acids. The results suggest raised SRB levels in UC, which could contribute to the condition through release of toxic sulphide.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23941288     DOI: 10.3109/09637486.2013.825700

Source DB:  PubMed          Journal:  Int J Food Sci Nutr        ISSN: 0963-7486            Impact factor:   3.833


  14 in total

Review 1.  Personalizing protein nourishment.

Authors:  David C Dallas; Megan R Sanctuary; Yunyao Qu; Shabnam Haghighat Khajavi; Alexandria E Van Zandt; Melissa Dyandra; Steven A Frese; Daniela Barile; J Bruce German
Journal:  Crit Rev Food Sci Nutr       Date:  2017-10-13       Impact factor: 11.176

Review 2.  Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier.

Authors:  Shui-Jiao Chen; Xiao-Wei Liu; Jian-Ping Liu; Xi-Yan Yang; Fang-Gen Lu
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

3.  Colonisation of the colonic mucus gel layer with butyrogenic and hydrogenotropic bacteria in health and ulcerative colitis.

Authors:  Helen Earley; Grainne Lennon; J Calvin Coffey; Desmond C Winter; P Ronan O'Connell
Journal:  Sci Rep       Date:  2021-03-31       Impact factor: 4.379

Review 4.  The Natural Antimicrobial Enzyme Lysozyme is Up-Regulated in Gastrointestinal Inflammatory Conditions.

Authors:  Carlos A Rubio
Journal:  Pathogens       Date:  2014-01-16

Review 5.  Hydrogen cross-feeders of the human gastrointestinal tract.

Authors:  Nick W Smith; Paul R Shorten; Eric H Altermann; Nicole C Roy; Warren C McNabb
Journal:  Gut Microbes       Date:  2018-12-18

6.  Determination of the prebiotic activity of wheat arabinogalactan peptide (AGP) using batch culture fermentation.

Authors:  Suzanne Harris; Stephen Powers; Andrea Monteagudo-Mera; Ondrej Kosik; Alison Lovegrove; Peter Shewry; Dimitris Charalampopoulos
Journal:  Eur J Nutr       Date:  2019-02-06       Impact factor: 5.614

7.  Examination of hydrogen cross-feeders using a colonic microbiota model.

Authors:  Nick W Smith; Paul R Shorten; Eric Altermann; Nicole C Roy; Warren C McNabb
Journal:  BMC Bioinformatics       Date:  2021-01-06       Impact factor: 3.169

Review 8.  Dietary Considerations in Autism Spectrum Disorders: The Potential Role of Protein Digestion and Microbial Putrefaction in the Gut-Brain Axis.

Authors:  Megan R Sanctuary; Jennifer N Kain; Kathleen Angkustsiri; J Bruce German
Journal:  Front Nutr       Date:  2018-05-18

Review 9.  Does Modification of the Large Intestinal Microbiome Contribute to the Anti-Inflammatory Activity of Fermentable Fiber?

Authors:  Shiu-Ming Kuo
Journal:  Curr Dev Nutr       Date:  2017-11-28

10.  Bioaccessibility of Difenoconazole in Rice Following Industry Standard Processing and Preparation Procedures.

Authors:  M Craggs; G R Gibson; P Whalley; C D Collins
Journal:  J Agric Food Chem       Date:  2020-09-08       Impact factor: 5.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.